Bildnachweis: Institute of Pathology of the Charité University Hospital. The focus of biotech company formation is primarily ...

alike, actively supported by a business-friendly government and public sector. The Hong Kong ecosystem counts more than 4,600 startups dominated by fintech, ICT, e-commerce, education, and learning as ...

Bildnachweis: neoplas med, WITENO, neoplas med. neoplas med GmbH from Greifswald, Germany, is considered a pioneer in medical cold plasma therapy. The company has been setting standards since its ...

Bildnachweis: Baker Tilly. The IPO of young, innovative growth companies in Germany has hardly been successful to date, as the associated cost, publicity and transparency requirements still place a ...

Bildnachweis: Kaoun International / GITEX. Germany’s start-ups are off to a great start in 2025. As per the KfW Venture Capital Dashboard, high-potential German ventures raked in EUR 1.6 billion in ...

Bildnachweis: Taylor Wessing, VentureCapital Magazin. When using AI in clinical trials, stakeholders point to the challenges associated with the use of AI in clinical trials, amongst others the need ...

Bildnachweis: (C) 0100 Conferences, 0100Conferences. The current environment is one of increased regulation and scrutiny, which has led to increased pressure on firms’ CFOs and COOs to manage their ...

Bildnachweis: Pexels, IFB Innovationsstarter, Baltic Business Angels Schleswig-Holstein, NBank Capital, Gründerfonds Ruhr, Jordana Schramm, bm | t beteiligungsmanagement thüringen, futureSAX, ...

Der Gewinner des Strüngmann Awards steht fest: Araris Biotech wurde von der Jury ausgezeichnet. Die Verleihung findet zum ...

Bildnachweis: ox8 Corporate Finance. Wenn der Exit ins Stocken gerät, ist Beratung mehr denn je gefragt. Der M&A-Markt steht ...

Mit einem jährlichen Fördervolumen von über 10 Mrd. EUR will die Europäische Kommission Europa bis 2030 zum weltweit ...

Bildnachweis: Omnes Capital. Der auf Deeptech spezialisierte Fondsanbieter Omnes Capital hat beim First Closing seines neuen ...